Brazil's Anti-Smoking Project in Amazon: Progress and Challenges

Regulations by 2FIRSTS.ai
May.16.2024
Brazil's Anti-Smoking Project in Amazon: Progress and Challenges
Representatives from Amazonas met at FCecon to discuss advancing the tobacco control project, aiming to reduce smoking rates.

According to Brazilian media reports on May 15th, representatives from the local government of Amazonas and coordinators of national and state-level tobacco control programs met at the Amazonas State Cancer Control Foundation (FCecon) to discuss how to further advance the project. The meeting was attended by Gerson Mourão, director of the Amazonas State Cancer Control Foundation, and representatives from the Amazonas State Health Department (SES-AM).

 

The National Tobacco Control Program (PNCT) is a joint initiative of the Brazilian Ministry of Health and the Brazilian National Cancer Institute (Inca) with a 20-year history. The aim of the program is to reduce smoking rates and smoking- related death rates. In the Amazon region, these activities are primarily carried out by the Amazonas State Cancer Control Center Foundation (FCecon).

 

Aristóteles Alencar, the state coordinator of the Amazonas Tobacco Control Program, stated that Amazonas ranked third in the country for the number of tobacco consumers who quit smoking, achieving remarkable results. He mentioned that the visit from the team of the Brazilian National Cancer Institute (Inca) was to understand the effective actions that have led to Amazonas reaching high quit smoking rates.

 

He pointed out, "Despite the vast expanse of the region and the many logistical challenges, the Brazilian National Cancer Institute (Inca) chose the Amazonas state as its research subject because we have achieved the lowest smoking rates nationwide. Our model can be replicated in other places. The key factors to success include the Amazonas State Cancer Control Center Foundation disseminating information to the public, as well as collaborating with the city and state education departments (Seduc and Semed) to host events promoting anti-smoking campaigns with children, and so on.

 

Alanaca added that, currently, the project is in its second phase. The project aims to expand anti-smoking activities to other areas and places a strong emphasis on understanding the unique environmental factors of each location in order to improve the health of the local population. The purpose of this meeting is to gather the strength of various organizations and individuals to enhance the effectiveness and sustainability of the anti-smoking project. The meeting also aims to raise awareness among regional representatives of the significant economic costs of the diseases and loss of life caused by smoking.

 

This type of epidemic has caused losses of up to 125 billion reais to our country, and we can only recover 10% of that amount from taxes. The amount itself is already unacceptable," expressed Alencar.

 

In addition, consultants Lucas Cabral and Érica Cavalcante from the Brazilian National Cancer Institute emphasized the efforts of institutions such as the Brazilian Ministry of Health (MS) in safeguarding public health and combating tobacco consumption.

 

Lucas Cabral stated: "We need to learn and understand from ourselves as the foundation for improving and integrating public policies, which are implemented by the Brazilian Ministry of Health and the Brazilian National Cancer Institute.

 

The project aims to ensure the strength of domestic tobacco control actions while also taking sustainability into consideration.

 

Due to limited health budget, we first chose five states, one in each region. Now, through discussions with state coordinating bodies, we hope to understand their weaknesses and strengths, and together advance anti-smoking campaigns," explained Kaval Kant.

 

Next, a team from the Brazilian National Cancer Institute and local partners will hold a meeting with professionals responsible for assisting smokers in quitting. They will discuss topics such as tobacco prevention, creating smoke-free environments, and treatment for e-cigarette use.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii has enacted two new e-cigarette laws that significantly tighten market access requirements, requiring products to meet FDA authorization standards and banning disposable e-cigarette sales starting in 2027.
Jul.08
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
The UK Department of Health and Social Care published new guidance on Aug. 11 outlining the next phase of retail rules under the Tobacco and Vapes Act 2026, which will take effect on Oct. 29, 2026. The measures extend the minimum age of sale of 18 to all vaping and consumer nicotine products and restrict proxy purchasing, promotional giveaways and substantial discounts. Relevant offences in England, Wales and Scotland may carry a £200 fixed penalty notice, while persistent offenders can face temporary sales bans.
Aug.12
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
A Scottish government impact assessment estimates that proposed vape display and packaging rules could create up to £61 million ($82 million) in compliance costs for businesses, affecting more than 11,000 retail outlets. The estimated costs are mainly linked to inventory adjustments, retail storage changes and the resources required for businesses to understand and implement the new requirements. The measures form part of the UK’s broader efforts to tighten vape regulation, particularly around product displays, packaging and sales practices.
Aug.10